RF&L Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.78M Buy
3,270
+1
+0% +$1.18K 2.54% 14
2026
Q2
$3.92M Sell
3,269
-100
-3% -$102K 2.65% 14
2026
Q1
$3.1M Sell
3,369
-161
-5% -$163K 2.32% 14
2025
Q4
$3.79M Sell
3,530
-149
-4% -$142K 2.13% 19
2025
Q3
$2.81M Sell
3,679
-25
-0.7% -$18.6K 1.65% 22
2025
Q2
$2.89M Hold
3,704
– – 1.86% 20
2025
Q1
$3.06M Hold
3,704
– – 2.19% 17
2024
Q4
$2.86M Hold
3,704
– – 2.02% 17
2024
Q3
$3.28M Sell
3,704
-30
-0.8% -$27K 2.32% 17
2024
Q2
$3.38M Sell
3,734
-150
-4% -$120K 2.57% 15
2024
Q1
$3.02M Sell
3,884
-330
-8% -$235K 2.33% 17
2023
Q4
$2.46M Sell
4,214
-100
-2% -$58.4K 2.04% 16
2023
Q3
$2.32M Sell
4,314
-360
-8% -$186K 2.15% 15
2023
Q2
$2.19M Sell
4,674
-370
-7% -$155K 2% 16
2023
Q1
$1.73M Sell
5,044
-150
-3% -$50.6K 1.68% 16
2022
Q4
$1.9M Buy
+5,194
New +$1.84M 1.96% 15

Other funds holding LLY

RF&L Wealth Management's LLY Position: Q3 2026 in Review

RF&L Wealth Management increased its Eli Lilly (LLY) stake by 0.03% in Q3 2026, buying an estimated $1.18K and bringing the position to 3,270 shares worth $3.78M. The position accounts for 2.54% of the portfolio, ranked #14.

RF&L Wealth Management first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $3.92M in Q2 2026. 1,134 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • RF&L Wealth Management held 3,270 shares of Eli Lilly worth $3.78M as of Q3 2026.
  • RF&L Wealth Management bought 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
  • Eli Lilly made up 2.54% of RF&L Wealth Management's portfolio in Q3 2026, its #14 holding.
  • RF&L Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
  • RF&L Wealth Management's Eli Lilly position peaked at $3.92M in Q2 2026.
  • 1,134 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on RF&L Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.